ArticleOncogene2019
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer.
Shun-Qing Liang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
this papercites it